Clinical Risk Factors of Subclinical Spread in Melanoma in Situ and Invasive Melanoma.
James Feng, Payal Shah, Rachael Chacko, Matthew J Davis, Matthew LeBoeuf
Author Information
- James Feng: Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
- Payal Shah: Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire.
- Rachael Chacko: Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
- Matthew J Davis: Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire.
- Matthew LeBoeuf: Department of Dermatology, Dartmouth Health, Lebanon, New Hampshire.
No abstract text available.
- Friedman EB, Scolyer RA, Williams GJ, Thompson JF. Melanoma in situ: a critical review and re-evaluation of current excision margin recommendations. Adv Ther 2021;38:3506–30.
- Etzkorn JR, Sobanko JF, Shin TM, Elenistas R, et al. Correlation between appropriate use criteria and the frequency of subclinical spread or reconstruction with a flap or graft for melanomas treated with Mohs surgery with melanoma antigen recognized by T cells 1 immunostaining. Dermatol Surg 2016;42:471–6.
- Connolly SM, Baker DR, Coldiron BM, Fazio MJ, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs surgery. Dermatol Surg 2012;38:1582–603.
- Shin TM, Etzkorn JR, Sobanko JF, Margolis DJ, et al. Clinical factors associated with subclinical spread of in situ melanoma. J Am Acad Dermatol 2017;76:707–13.
- Shin TM, Shaikh WR, Etzkorn JR, Sobanko JF, et al. Clinical and pathologic factors associated with subclinical spread of invasive melanoma. J Am Acad Dermatol 2017;76:714–21.
